RedShiftBio Lab Photo
Redshiftbio
App Notes
App Notes
Structural Analysis of Antibody Drug Conjugates: Key Insights

Structural Characterization of Antibody Drug Conjugates as Formulated and Under Multiple Conjugation Paradigms

September 20, 2024

Abstract

Antibody Drug Conjugates (ADCs) combine the specificity of a monoclonal antibody (mAb) with the cytotoxicity of small molecule therapeutics. Biophysical characterization, including the analysis of the conformation and higher-order structure (HOS) of the mAb before and after drug conjugation, is a critical aspect to understanding the stability and eventual efficacy of the ADC. In this study, Trastuzumab-based ADCs are studied using MMS, a novel infrared-based biophysical technique. ADCs produced by two different conjugation methods are structurally compared using the MMS data. Results reveal significant structural discrepancies from the different conjugation methods. These structural differences ultimately contribute to a change in thermal stability of the ADCs measured by Differential Scanning Calorimetry (DSC).

Please complete the form to download the full app note.

Thank you for submitting the form. A member of our team will reach out shortly.
Oops! Something went wrong while submitting the form.

Request a Demo Today! 

RedShiftBio AQS3 Product Detail